Education
About Us
Working with TipRanks
Follow Us
Oncology Institute, Inc. (TOI)
NASDAQ:TOI
Total Valuation
Oncology Institute has a market cap or net worth of $197.61M. The enterprise value is $214.28M.
Market Cap$197.61M
Enterprise Value$214.28M
Share Statistics
Oncology Institute has 91,913,734 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,913,734
Owned by Insiders23.19%
Owned by Institutions12.42%
Financial Efficiency
Oncology Institute’s return on equity (ROE) is -18.02 and return on invested capital (ROIC) is -44.83%.
Return on Equity (ROE)-18.02
Return on Assets (ROA)-0.37
Return on Invested Capital (ROIC)-44.83%
Return on Capital Employed (ROCE)-0.50
Revenue Per Employee476.86K
Profits Per Employee-78.38K
Employee Count825
Asset Turnover2.28
Inventory Turnover33.81
Valuation Ratios
The current PE Ratio of Oncology Institute is -0.36. Oncology Institute’s PEG ratio is -0.63.
PE Ratio-0.36
PS Ratio0.00
PB Ratio0.96
Price to Fair Value6.46
Price to FCF-1.79
Price to Operating Cash Flow-1.94
PEG Ratio-0.63
Income Statement
In the last 12 months, Oncology Institute had revenue of 393.41M and earned -64.66M in profits. Earnings per share was 0.00.
Revenue393.41M
Gross Profit54.00M
Operating Income-60.12M
Pretax Income-64.66M
Net Income-64.66M
EBITDA-50.88M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -15.64M and capital expenditures -3.51M, giving a free cash flow of -19.15M billion.
Operating Cash Flow-15.64M
Free Cash Flow-19.15M
Free Cash Flow per Share-0.21
Dividends & Yields
Oncology Institute pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.59
52-Week Price Change397.78%
50-Day Moving Average2.71
200-Day Moving Average1.09
Relative Strength Index (RSI)39.46
Average Volume (3m)1.97M
Important Dates
Oncology Institute upcoming earnings date is Aug 12, 2025, After Close (Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 12, 2025
Ex-Dividend Date―
Financial Position
Oncology Institute as a current ratio of 2.15, with Debt / Equity ratio of 86.77%
Current Ratio2.15
Quick Ratio1.96
Debt to Market Cap4.31
Net Debt to EBITDA-1.44
Interest Coverage Ratio-8.02
Taxes
In the past 12 months, Oncology Institute has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Oncology Institute EV to EBITDA ratio is -1.90, with an EV/FCF ratio of -3.19.
EV to Sales0.25
EV to EBITDA-1.90
EV to Free Cash Flow-3.19
EV to Operating Cash Flow-3.64
Balance Sheet
Oncology Institute has $39.74M in cash and marketable securities with $102.31M in debt, giving a net cash position of $62.57M billion.
Cash & Marketable Securities$39.74M
Total Debt$102.31M
Net Cash$62.57M
Net Cash Per Share$0.68
Tangible Book Value Per Share-$0.25
Margins
Gross margin is 20.63%, with operating margin of -15.28%, and net profit margin of -16.44%.
Gross Margin20.63%
Operating Margin-15.28%
Pretax Margin-16.44%
Net Profit Margin-16.44%
EBITDA Margin-12.93%
EBIT Margin-14.53%
Analyst Forecast
The average price target for Oncology Institute is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside225.58% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast17.64%
EPS Growth Forecast13.86%